T-Wave alternans for arrhythmia risk stratification in patients with idiopathic dilated cardiomyopathy**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.  by Verrier, Richard L et al.
EDITORIAL COMMENT
T-Wave Alternans for Arrhythmia
Risk Stratification in Patients
With Idiopathic Dilated
Cardiomyopathy*
Richard L. Verrier, PHD, FACC,
Aneesh V. Tolat, MD,
Mark E. Josephson, MD, FACC
Boston, Massachusetts
Identification of individuals at risk for life-threatening
arrhythmias has proved to be challenging in patients with
nonischemic heart disease in general and in those with
idiopathic dilated cardiomyopathy (DCM) in particular.
This is an important clinical problem, as DCM accounts for
approximately 10% of all adult sudden cardiac deaths and
has a one-year mortality of 10% to 50% (1,2). Most of the
patients afflicted by this condition have no definable etiology
for the cardiomyopathic process that underlies their com-
plex, highly arrhythmogenic myocardial substrate. The
mainstay for arrhythmia risk evaluation, electrophysiologic
testing, has proved to be of limited utility (1,3–5). Other
investigators have determined that depressed heart rate
variability (HRV) and late potentials on signal-averaged
electrocardiogram (SAECG) are potentially useful in eval-
uating arrhythmia risk in patients with DCM (6,7), but QT
dispersion has not proved to be reliable.
See page 2220
In this issue of the Journal, Hohnloser et al. (8) evaluate
the utility of microvolt T-wave alternans (MTWA), a
parameter that is routinely measured during exercise testing
with bicycle ergometry or treadmill. Additional determina-
tions included a battery of contemporary risk stratifiers,
namely left ventricular ejection fraction, baroreflex sensitiv-
ity (BRS), mean heart rate, HRV, presence of nonsustained
ventricular tachycardia, SAECG, and presence of intraven-
tricular conduction defect, in predicting ventricular tachy-
arrhythmic events in patients with DCM. Only MTWA
and BRS were found to be significant univariate predictors
of events. Hohnloser et al. focused on MTWA because of a
growing body of experimental and clinical evidence support-
ing the potential utility of this end point in assessing
cardiac electrical instability, particularly in patients with
underlying ischemic heart disease (9 –11). The present
study population consisted of a mixture of 100 patients
who were evaluated for primary prevention, as well as 37
patients who had already suffered a clinical event and
undergone implantation of an implantable cardioverter/
defibrillator (ICD). In those with determinate tests,
MTWA by Kaplan-Meier analysis was found to be a
potent predictor of ventricular tachyarrhythmic events
and arrhythmia-free survival (p  0.035) during an average
of 14 months of follow-up. Thus, the present prospective
observational study enrolling a sizeable number of individ-
uals with a nonischemic substrate represents an important
contribution.
Two central caveats remain. The first is that the relatively
high indeterminacy rate is a limitation of the test. In this
study, 27% of patients had indeterminate results even after
exclusion of patients with atrial fibrillation. This is consis-
tent with previous studies that have reported indeterminacy
rates from 20% to 40% (12). Almost half (18/37 or 49%) of
patients with indeterminate test results were unable to
achieve a heart rate of 105 beats/min with exercise. Three of
the patients with events in follow-up had indeterminate
tests and were not included in Kaplan-Meier analysis. The
second main limitation is that the study population of 137
patients included 37 who already had ICD implantation
based on overt manifestation of their high-risk status. Their
inclusion introduces a selection bias, as the likelihood both
of an event and an MTWA positive test was inherently
greater in these patients. Although inclusion of this group of
patients to achieve an adequate event rate appears justifiable,
it nonetheless limits the inferences that can be drawn from
the study. Because the reported odds ratio for events in
non-ICD patients was relatively low, 1.93  2.2, further
studies will be required to assess whether MTWA might
have a role in the identification of DCM patients without
previous clinical events who are at risk for life-threatening
arrhythmias.
It is important to consider that MTWA values are usually
obtained during exercise. This fact raises the possibility that
provocative testing of the myocardial substrate may contrib-
ute to its capacity to stratify risk. This feature of MTWA
testing may hold intrinsic advantages over other measures
such as QT dispersion and SAECG, which are typically
made at rest. Although no MTWA results are reported in
patients at rest in the current study, the general experi-
ence with this parameter in patients with ischemic heart
disease is that prognostic power is superior during exer-
cise testing (11,12). The stimulus of exercise incorporates
a number of potential proarrhythmic influences in addi-
tion to elevation in heart rate, notably an increase in
plasma catecholamine levels (13), which may be impor-
tant in inducing T-wave alternans (TWA) as a marker of
electrical instability.
The electrophysiologic basis for arrhythmogenesis in
patients with DCM is unknown. This deficiency relates in
part to the complexities of derangements in the myocardial
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substrate of these patients. Koumi et al. (14) demonstrated
that ventricular myocytes from DCM patients had a longer
action potential duration and slower repolarization phase 3
of the action potential than those from ischemic hearts and
suggested differences in the rectifying K channel. Kawara
et al. (15) provided histological evidence that the architec-
ture of fibrosis in DCM contributes to activation delay. Hsia
and Marchlinski (16) provided evidence that abnormal
tissue either from scar or fatty tissue infiltration may lead to
abnormal conduction and subsequent heterogeneity of re-
polarization in patients with DCM. Major disturbances in
calcium handling (17–19) and enhanced adrenergic stimu-
lation (20,21) have been implicated in both DCM and
hypertrophic cardiomyopathy. The role of conduction ab-
normalities in heterogeneity of recovery of excitability needs
further evaluation. Although unproven, it is likely that the
vulnerable substrate of patients with nonischemic disease
may be susceptible to transient factors such as alterations in
neural activity and electrolyte imbalance in the initiation of
disturbances in cardiac repolarization and ventricular ar-
rhythmogenesis (2).
Several of these arrhythmogenic characteristics of DCM
have been shown experimentally to increase TWA, support-
ing the rationale for investigating TWA as a potential
marker of risk in DCM. Specifically, TWA provides a
quantitative measure of temporal and spatial unevenness of
repolarization (9,11,22), which is likely to be present in the
irregular fibrotic substrate in DCM patients (16). A link
between disturbed calcium handling and TWA is supported
in experimental models by the fact that repolarization
alternans occurs in concert with oscillations in calcium
fluorescence (23–25) and during intracellular calcium over-
load (26,27). Conversely, TWA can be prevented by cal-
cium antagonists (28) and by ryanodine, an inhibitor of
sarcoplasmic reticulum calcium reuptake (29,30). The ca-
pacity of TWA to detect the influences of adrenergic
activity is suggested by the facts that TWA magnitude is
increased by sympathetic nerve stimulation and behavioral
stress in both humans and animals (31–33) and blunted by
beta-adrenergic blockade (34,35).
In summary, Hohnloser et al. (8) have provided promis-
ing results regarding the value of MTWA in risk stratifying
patients with DCM. Their findings also underscore the
potential value of physiologically provocative testing to
uncover latent electrical instability in these patients. In the
future, dynamic evaluation may not be restricted to exercise
testing, because methodological developments have been
made that permit assessment of TWA during ambulatory
monitoring (36).
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